• Samik Pharmaceutical executive Kwon Young Ee cut her stake to 40,000 shares, or 0.40%, from 60,000 shares, or 0.60%.
• The change followed an on-market sale of 20,000 common shares on Sept. 17 at KRW 11,000 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samik Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260923000239), on September 23, 2026, and is solely responsible for the information contained therein.